Guidance Point Advisors’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.98M Buy
315,676
+11,699
+4% +$298K 1.89% 11
2025
Q4
$7.76M Buy
303,977
+22,018
+8% +$564K 1.8% 11
2025
Q3
$7.22M Buy
281,959
+3,546
+1% +$90K 1.74% 10
2025
Q2
$7.04M Buy
278,413
+2,261
+0.8% +$56.1K 1.81% 9
2025
Q1
$6.9M Buy
276,152
+3,527
+1% +$87.2K 1.97% 10
2024
Q4
$6.7M Buy
272,625
+5,917
+2% +$148K 1.88% 11
2024
Q3
$6.86M Sell
266,708
-11,604
-4% -$293K 2% 11
2024
Q2
$6.84M Buy
278,312
+44,547
+19% +$1.09M 2.13% 11
2024
Q1
$5.8M Buy
233,765
+25,430
+12% +$630K 1.89% 13
2023
Q4
$5.26M Buy
208,335
+43,061
+26% +$1.03M 1.94% 11
2023
Q3
$3.88M Buy
165,274
+14,778
+10% +$357K 1.58% 13
2023
Q2
$3.71M Buy
+150,496
New +$3.73M 1.42% 17

Other funds holding IBDX

Guidance Point Advisors's IBDX Position: Q1 2026 in Review

Guidance Point Advisors increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 3.8% in Q1 2026, buying an estimated $298K and bringing the position to 315,676 shares worth $7.98M. The position accounts for 1.89% of the portfolio, ranked #11.

Guidance Point Advisors first reported a position in IBDX in Q2 2023 and has held it in 12 quarters since. 221 funds tracked by Wall St. Rank hold IBDX as of Q1 2026.

  • Guidance Point Advisors held 315,676 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $7.98M as of Q1 2026.
  • Guidance Point Advisors bought 11,699 iShares iBonds Dec 2032 Term Corporate ETF shares in Q1 2026, an estimated $298K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 1.89% of Guidance Point Advisors's portfolio in Q1 2026, its #11 holding.
  • Guidance Point Advisors first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q2 2023 and has held it in 12 quarters since.
  • 221 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q1 2026.

Based on Guidance Point Advisors's 13F filing for Q1 2026, filed 12 May 2026.